225 related articles for article (PubMed ID: 16632213)
1. Pathologic reporting and special diagnostic techniques for melanoma.
Cochran AJ; Starz H; Ohsie SJ; Sarantopoulos GP; Haas CJ; Binder S
Surg Oncol Clin N Am; 2006 Apr; 15(2):231-51. PubMed ID: 16632213
[TBL] [Abstract][Full Text] [Related]
2. Pathology of melanocytic lesions: new, controversial, and clinically important issues.
Scolyer RA; Thompson JF; Stretch JR; Sharma R; McCarthy SW
J Surg Oncol; 2004 Jul; 86(4):200-11. PubMed ID: 15221927
[TBL] [Abstract][Full Text] [Related]
3. Melanoma pathology: important issues for clinicians involved in the multidisciplinary care of melanoma patients.
Scolyer RA; Prieto VG
Surg Oncol Clin N Am; 2011 Jan; 20(1):19-37. PubMed ID: 21111957
[TBL] [Abstract][Full Text] [Related]
4. Surgical management of primary cutaneous melanoma: excision margins and the role of sentinel lymph node examination.
Thompson JF; Scolyer RA; Uren RF
Surg Oncol Clin N Am; 2006 Apr; 15(2):301-18. PubMed ID: 16632216
[TBL] [Abstract][Full Text] [Related]
5. The advantage of using a synoptic pathology report format for cutaneous melanoma.
Karim RZ; van den Berg KS; Colman MH; McCarthy SW; Thompson JF; Scolyer RA
Histopathology; 2008 Jan; 52(2):130-8. PubMed ID: 18184262
[TBL] [Abstract][Full Text] [Related]
6. Sentinel lymph node biopsy for patients with diagnostically controversial Spitzoid melanocytic tumors?
Busam KJ; Pulitzer M
Adv Anat Pathol; 2008 Sep; 15(5):253-62. PubMed ID: 18724099
[TBL] [Abstract][Full Text] [Related]
7. Impact of false-negative sentinel lymph node biopsy on survival in patients with cutaneous melanoma.
Caracò C; Marone U; Celentano E; Botti G; Mozzillo N
Ann Surg Oncol; 2007 Sep; 14(9):2662-7. PubMed ID: 17597345
[TBL] [Abstract][Full Text] [Related]
8. Novel imaging techniques in melanoma.
Essner R; Belhocine T; Scott AM; Even-Sapir E
Surg Oncol Clin N Am; 2006 Apr; 15(2):253-83. PubMed ID: 16632214
[TBL] [Abstract][Full Text] [Related]
9. [The latest diagnostical methods and therapy in melanoma].
Wojas-Pelc A; Rajzer L; Jaworek A; Woźniak W
Przegl Lek; 2006; 63(8):674-80. PubMed ID: 17441381
[TBL] [Abstract][Full Text] [Related]
10. Predicting sentinel node status in AJCC stage I/II primary cutaneous melanoma.
Kruper LL; Spitz FR; Czerniecki BJ; Fraker DL; Blackwood-Chirchir A; Ming ME; Elder DE; Elenitsas R; Guerry D; Gimotty PA
Cancer; 2006 Nov; 107(10):2436-45. PubMed ID: 17058288
[TBL] [Abstract][Full Text] [Related]
11. Highly sensitive multivariable assay detection of melanocytic differentiation antigens and angiogenesis biomarkers in sentinel lymph nodes with melanoma micrometastases.
Vitoux D; Mourah S; Kerob D; Verola O; Basset-Seguin N; Baccard M; Schartz N; Ollivaud L; Archimbaud A; Servant JM; Revol M; Toubert ME; Podgorniak MP; Plassa F; Porcher R; Lebbé C
Arch Dermatol; 2009 Oct; 145(10):1105-13. PubMed ID: 19841396
[TBL] [Abstract][Full Text] [Related]
12. New American Joint Commission on Cancer staging system for melanoma: prognostic impact and future directions.
Ross MI
Surg Oncol Clin N Am; 2006 Apr; 15(2):341-52. PubMed ID: 16632219
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of histopathological parameters in sentinel nodes of melanoma patients.
Shaw HM; Scolyer RA; Thompson JF
Histopathology; 2008 Jan; 52(2):242; author reply 242-4. PubMed ID: 18184275
[No Abstract] [Full Text] [Related]
14. Pathobiology of the sentinel node.
Cochran AJ; Ohsie SJ; Binder SW
Curr Opin Oncol; 2008 Mar; 20(2):190-5. PubMed ID: 18300769
[TBL] [Abstract][Full Text] [Related]
15. Evidence and interdisciplinary consense-based German guidelines: diagnosis and surveillance of melanoma.
Garbe C; Hauschild A; Volkenandt M; Schadendorf D; Stolz W; Reinhold U; Kortmann RD; Kettelhack C; Frerich B; Keilholz U; Dummer R; Sebastian G; Tilgen W; Schuler G; Mackensen A; Kaufmann R
Melanoma Res; 2007 Dec; 17(6):393-9. PubMed ID: 17992123
[TBL] [Abstract][Full Text] [Related]
16. [Prognosis after sentinel node biopsy in malignant melanoma].
Lock-Andersen J; Horn J; Sjøstrand H
Ugeskr Laeger; 2006 Jun; 168(25):2457-62. PubMed ID: 16824370
[TBL] [Abstract][Full Text] [Related]
17. Sentinel lymph node biopsy in cutaneous melanoma: a case-control study.
Koskivuo I; Talve L; Vihinen P; Mäki M; Vahlberg T; Suominen E
Ann Surg Oncol; 2007 Dec; 14(12):3566-74. PubMed ID: 17924169
[TBL] [Abstract][Full Text] [Related]
18. Interobserver variation in the histopathologic reporting of key prognostic parameters, particularly clark level, affects pathologic staging of primary cutaneous melanoma.
Murali R; Hughes MT; Fitzgerald P; Thompson JF; Scolyer RA
Ann Surg; 2009 Apr; 249(4):641-7. PubMed ID: 19300224
[TBL] [Abstract][Full Text] [Related]
19. Ki-67 expression in melanoma. A potential method of risk assessment for the patient with a positive sentinel node.
Pearl RA; Pacifico MD; Richman PI; Stott DJ; Wilson GD; Grobbelaar AO
J Exp Clin Cancer Res; 2007 Mar; 26(1):109-15. PubMed ID: 17550139
[TBL] [Abstract][Full Text] [Related]
20. Lymphatic invasion identified by monoclonal antibody D2-40, younger age, and ulceration: predictors of sentinel lymph node involvement in primary cutaneous melanoma.
Niakosari F; Kahn HJ; McCready D; Ghazarian D; Rotstein LE; Marks A; Kiss A; From L
Arch Dermatol; 2008 Apr; 144(4):462-7. PubMed ID: 18427039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
